Literature DB >> 7643951

Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data.

R C Holman1, A S Khan, J Kent, T W Strine, L B Schonberger.   

Abstract

The trends and current incidence of Creutzfeldt-Jakob disease (CJD) was examined by using a unique and potentially high sensitive source for case ascertainment. We analyzed death certificate information for 1979-1990 from US multiple-cause-of-death mortality data, compiled by the National Center for Health Statistics, Centers for Disease Control and Prevention. We evaluated death certificate data for US residents for whom CJD was listed as one of the multiple causes of death on the death certificate (046.1) from the International Statistical Classification of Diseases, Injuries, and Causes of Death (9th revision). Age-adjusted and age-specific CJD death rates by gender, race, and region were calculated to measure the disease incidence because of the rapidly fatal course of the disease for most patients with CJD. We identified 2,614 deaths with CJD listed on the death certificates. The average annual age-adjusted mortality rate was 0.9 deaths per million persons (range 0.8-1.1). The mean age at death was 67 years. CJD-related deaths were uncommon among persons younger than 50 years of age (4.3% of all deaths). The highest average annual mortality rate was for those persons aged 70-74 years (5.9 deaths per million persons). A slight majority (53.0%) of the deaths was in females, but the age-adjusted mortality rate was 1.2 times higher for males. Most deaths (94.8%) were in whites; the mortality rate for blacks was only 40% of that for whites. The age-adjusted CJD mortality rate in the United States is similar to published estimates of the crude incidence of CJD worldwide.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7643951     DOI: 10.1159/000109793

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  10 in total

1.  Rate of Creutzfeldt-Jakob disease in farmers is not significant.

Authors:  D R Morrison
Journal:  BMJ       Date:  1996-08-31

2.  Mad cow disease. An opportunity for preventive medicine?

Authors:  P Salzmann; S Saint; L M Tierney
Journal:  West J Med       Date:  1997-12

3.  Creutzfeldt-Jakob disease in Austria.

Authors:  J A Hainfellner; K Jellinger; H Diringer; M Guentchev; R Kleinert; P Pilz; H Maier; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

Review 4.  Is Creutzfeldt-Jakob disease transmitted in blood?

Authors:  M N Ricketts; N R Cashman; E E Stratton; S ElSaadany
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

5.  Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.

Authors:  R C Holman; A S Khan; E D Belay; L B Schonberger
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

6.  Creutzfeldt-Jakob disease in Sweden.

Authors:  P O Lundberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

7.  Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease.

Authors:  Alexander H Peden; Diane L Ritchie; Mark W Head; James W Ironside
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 8.  Ensuring the biologic safety of plasma-derived therapeutic proteins: detection, inactivation, and removal of pathogens.

Authors:  Kang Cai; Todd M Gierman; JoAnn Hotta; Christopher J Stenland; Douglas C Lee; Dominique Y Pifat; Steve R Petteway
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

9.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

10.  Creutzfeldt-Jakob disease mortality in Japan, 1979-2004: analysis of national death certificate data.

Authors:  Yuriko Doi; Tetsuji Yokoyama; Miyoshi Sakai; Yosikazu Nakamura
Journal:  J Epidemiol       Date:  2007-07       Impact factor: 3.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.